Lung Cancer's Harsh Reality
Kevetrin™ - success in animal models Companies such as Cellceutix are doing research in lung cancer due to the high incidence of lung cancer and poor survival rates, which create a high level of medical need. We at Cellceutix recently announced some very promising results of a series of animal tests of our lead compound, Kevetrin™, in two multi-drug resistant lung cancer cell lines (A549 & NCI-H1975).
Sitemap